Does USTEKINUMAB Cause Hypersensitivity vasculitis? 23 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Hypersensitivity vasculitis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.0% of all adverse event reports for USTEKINUMAB.
23
Reports of Hypersensitivity vasculitis with USTEKINUMAB
0.0%
of all USTEKINUMAB reports
1
Deaths
11
Hospitalizations
How Dangerous Is Hypersensitivity vasculitis From USTEKINUMAB?
Of the 23 reports, 1 (4.3%) resulted in death, 11 (47.8%) required hospitalization, and 2 (8.7%) were considered life-threatening.
Is Hypersensitivity vasculitis Listed in the Official Label?
Yes, Hypersensitivity vasculitis is listed as a known adverse reaction in the official FDA drug label for USTEKINUMAB.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Hypersensitivity vasculitis?
ADALIMUMAB (147)
INFLIXIMAB (97)
METHOTREXATE (89)
ETANERCEPT (81)
RITUXIMAB (69)
RIVAROXABAN (67)
AZATHIOPRINE (66)
FUROSEMIDE (63)
PREDNISONE (63)
AMLODIPINE (54)
Which USTEKINUMAB Alternatives Have Lower Hypersensitivity vasculitis Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE